You are here

A Study of the Safety, Tolerability, and Pharmacokinetics of AGG-523 in Healthy Japanese Males

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
Ikebukuro, Tokyo, 1520003 Japan
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Healthy
Sex
Male
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
20-40 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Men aged 20 to 40 years, inclusive, at screening; sexually active men must agree to
use a medically acceptable form of contraception during the study and continue for 12
weeks after test article administration.

- Body mass index (BMI) in the range of 17.6 to 26.4 Kgm2, and body weight >45 kg.

- Healthy as determined by the investigator on the basis of medical history, physical
examination, clinical laboratory test results, vital signs, and 12 lead ECG.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Men aged 20 to 40 years, inclusive, at screening; sexually active men must agree to
use a medically acceptable form of contraception during the study and continue for 12
weeks after test article administration.

- Body mass index (BMI) in the range of 17.6 to 26.4 Kgm2, and body weight >45 kg.

- Healthy as determined by the investigator on the basis of medical history, physical
examination, clinical laboratory test results, vital signs, and 12 lead ECG.

NCT00434785
Pfizer
Completed
A Study of the Safety, Tolerability, and Pharmacokinetics of AGG-523 in Healthy Japanese Males

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now